OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 23, 2019
FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.
September 19, 2018
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.
March 16, 2018
Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.
October 01, 2017
There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.
July 14, 2016
A new study examines the oral delivery of protein drugs in plant cells and hypothesizes that the cold storage and transportation of biologics could someday be eliminated.
August 26, 2015
The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.
August 03, 2015
FDA issues draft guidance on dissolution testing for immediate-release solid oral dosage forms.
July 16, 2013
Almac's Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.